Search results: Sage Journals

Open accessCase reportFirst published 2023

Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial

Zuzana Bielcikova, Lukas Werner, Jan Stursa [...]

Therapeutic Advances in Medical Oncology

Free accessResearch articleFirst published February, 2015

Comparison of adequate relief with symptom,global,and responder endpoints in linaclotide phase 3 trials in IBS-C

Michael Camilleri, Anthony J Lembo, Bernard J Lavins [...]

United European Gastroenterology Journal

Open accessResearch articleFirst published 2025

Xevinapant plus avelumab in advanced solid tumours,with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker,safety and efficacy analyses from an open-label,nonrandomised phase Ib study

Glenwood Goss, Tudor Ciuleanu, Rodryg Ramlau [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2019

Phase Ib study of the combination of pexidartinib (PLX3397),a CSF-1R inhibitor,and paclitaxel in patients with advanced solid tumors

Robert Wesolowski, Neelesh Sharma, Laura Reebel [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2023

Phase Ib study of HSP90 inhibitor,onalespib (AT13387),in combination with paclitaxel in patients with advanced triple-negative breast cancer

Nicole O. Williams, Dionisia Quiroga, Courtney Johnson [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2024

Dalpiciclib in combination with letrozole/anastrozole or fulvestrant in HR-positive and HER2-negative advanced breast cancer: results from a phase Ib study

Qingyuan Zhang, Pin Zhang, Min Yan [...]

Therapeutic Advances in Medical Oncology

Restricted accessBrief reportFirst published March, 2022

Pfizer Eyes Resuming Phase III Enrollment,Investigates Phase Ib Death Tied to Duchenne Muscular Dystrophy Candidate

Alex Philippidis

Human Gene Therapy

Open accessResearch articleFirst published 2025

Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)

Hiroki Osumi, Takeru Wakatsuki, Akira Ooki [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published January, 2004

Nolatrexed Phase Ib Clinical Trial in a Dose Intensificaiton Schedule in Advanced Cancer Patients

Charles Schloss, Michele Cronin, Fred Oldham [...]

Journal of Investigative Medicine

Restricted accessResearch articleFirst published May, 1997

Phase I/IB Study of Immunization with Autologous Tumor Cells Transfected with the GM-CSF Gene by Particle-Mediated Transfer in Patients with Melanoma or Sarcoma University of Wisconsin,Madison,Wisconsin

David M. Mahvi, P. M. Sondel, N-S Yang [...]

Human Gene Therapy

Open accessCase reportFirst published 2023

Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial

Zuzana Bielcikova, Lukas Werner, Jan Stursa [...]

Therapeutic Advances in Medical Oncology

Free accessResearch articleFirst published February, 2015

Comparison of adequate relief with symptom,global,and responder endpoints in linaclotide phase 3 trials in IBS-C

Michael Camilleri, Anthony J Lembo, Bernard J Lavins [...]

United European Gastroenterology Journal

Open accessResearch articleFirst published 2025

Xevinapant plus avelumab in advanced solid tumours,with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker,safety and efficacy analyses from an open-label,nonrandomised phase Ib study

Glenwood Goss, Tudor Ciuleanu, Rodryg Ramlau [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2019

Phase Ib study of the combination of pexidartinib (PLX3397),a CSF-1R inhibitor,and paclitaxel in patients with advanced solid tumors

Robert Wesolowski, Neelesh Sharma, Laura Reebel [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2023

Phase Ib study of HSP90 inhibitor,onalespib (AT13387),in combination with paclitaxel in patients with advanced triple-negative breast cancer

Nicole O. Williams, Dionisia Quiroga, Courtney Johnson [...]

Therapeutic Advances in Medical Oncology

Open accessResearch articleFirst published 2024

Dalpiciclib in combination with letrozole/anastrozole or fulvestrant in HR-positive and HER2-negative advanced breast cancer: results from a phase Ib study

Qingyuan Zhang, Pin Zhang, Min Yan [...]

Therapeutic Advances in Medical Oncology

Restricted accessBrief reportFirst published March, 2022

Pfizer Eyes Resuming Phase III Enrollment,Investigates Phase Ib Death Tied to Duchenne Muscular Dystrophy Candidate

Alex Philippidis

Human Gene Therapy

Open accessResearch articleFirst published 2025

Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)

Hiroki Osumi, Takeru Wakatsuki, Akira Ooki [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published January, 2004

Nolatrexed Phase Ib Clinical Trial in a Dose Intensificaiton Schedule in Advanced Cancer Patients

Charles Schloss, Michele Cronin, Fred Oldham [...]

Journal of Investigative Medicine

Restricted accessResearch articleFirst published May, 1997

Phase I/IB Study of Immunization with Autologous Tumor Cells Transfected with the GM-CSF Gene by Particle-Mediated Transfer in Patients with Melanoma or Sarcoma University of Wisconsin,Madison,Wisconsin

David M. Mahvi, P. M. Sondel, N-S Yang [...]

Human Gene Therapy